Companies: 10,638     total market cap: โ‚น12170.341 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
GlaxoSmithKline
GSK
#209
Rank
โ‚น8.778 T
Marketcap
๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom
Country
โ‚น4,349
Share price
-0.33%
Change (1 day)
53.76%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

GlaxoSmithKline (GSK) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น399.26 Billion

According to GlaxoSmithKline's latest financial reports the company has โ‚น399.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlaxoSmithKline - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น399.82 B-24.48%
2023-12-31โ‚น529.44 B-31.11%
2022-12-31โ‚น768.55 B85%
2021-12-31โ‚น415.44 B-32.46%
2020-12-31โ‚น615.06 B43.43%
2019-12-31โ‚น428.83 B22.07%
2018-12-31โ‚น351.29 B4.09%
2017-12-31โ‚น337.49 B-19.27%
2016-12-31โ‚น418.07 B-28.11%
2015-12-31โ‚น581.53 B33.73%
2014-12-31โ‚น434.85 B-23.8%
2013-12-31โ‚น570.67 B51.2%
2012-12-31โ‚น377.43 B-22.17%
2011-12-31โ‚น484.94 B12.33%
2010-12-31โ‚น431.71 B-17.18%
2009-12-31โ‚น521.23 B7.7%
2008-12-31โ‚น483.95 B36.82%
2007-12-31โ‚น353.70 B34.16%
2006-12-31โ‚น263.64 B-35.07%
2005-12-31โ‚น406.06 B22.79%
2004-12-31โ‚น330.69 B17.67%
2003-12-31โ‚น281.04 B48.04%
2002-12-31โ‚น189.84 B16.89%
2001-12-31โ‚น162.40 B-35.09%
2000-12-31โ‚น250.21 B81.18%
1999-12-31โ‚น138.09 B3.62%
1998-12-31โ‚น133.27 B24.21%
1997-12-31โ‚น107.29 B38.12%
1996-12-31โ‚น77.68 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
โ‚น735.04 B 84.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น1.346 T 237.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 309.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น876.17 B 119.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น938.96 B 135.17%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚น197.90 B-50.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚น58.19 B-85.42%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com